Pyridine Based Antitumour Compounds Acting at the Colchicine Site

Author(s): R. Álvarez, L. Aramburu, P. Puebla, E. Caballero, M. González, A. Vicente, M. Medarde, R. Peláez

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 11 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Antimitotics binding at the colchicine site of tubulin are important antitumour and vascular disrupting agents. Pyridines and azines are privileged scaffolds in medicinal chemistry and in recent years many colchicine site ligands (CSL) have incorporated them into their structures with the aim of improving their pharmacokinetic and pharmacodynamics properties. CSL have been classified according to their chemical structures and the chemical structures of the pyridine and azine containing antimitotic compounds are described. The designed principles behind the structural modifications and the achieved effect on the biological activity upon inclusion of these heterocycles are also discussed. Lessons from the achievements and failures have been extracted and future perspectives delineated.

Keywords: Pyridine, azines, antimitotics, tubulin, colchicine, antitumour, drug design.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [1100 - 1130]
Pages: 31
DOI: 10.2174/092986732311160420104823
Price: $65

Article Metrics

PDF: 59
PRC: 3